Browsing by Author Waldman, Boris

Jump to: 0-9 A B C D E F G H I J K L M N O P Q R S T U V W X Y Z
or enter first few letters:  
Showing results 1 to 3 of 3
Issue DateTitleAuthor(s)Citation
2017Baseline circulating FGF21 concentrations and increase after fenofibrate treatment predict more rapid glycemic progression in type 2 diabetes: Results from the FIELD studyBarter, Philip; Januszewski, Andrzej Szczesny; Jenkins, Alicia; Keech, Anthony (Tony); O'Connell, Rachel; Ong, Kwok; Rye, Kerry-Anne; Simes, Veronica; Sullivan, David; Waldman, Boris; Best, J; Colman, P; Scott, R; Taskinen, Marja-Riitta; Xu, A; Central Clinical School: Heart Research Institute; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; Central Clinical School: Heart Research Institute; Central Clinical School: Heart Research Institute; Plant & Food Sciences; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreBaseline circulating FGF21 concentrations and increase after fenofibrate treatment predict more rapid glycemic progression in type 2 diabetes: Results from the FIELD study, Clinical Chemistry, vol.63, 7, 2017,pp 1261-1270
2017HDL as a Target for Glycemic ControlJenkins, Alicia; Keech, Anthony (Tony); Sullivan, David; Waldman, Boris; Ng, Martin K C; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials Centre; NH&MRC Clinical Trials CentreHDL as a Target for Glycemic Control, Current Drug Targets, vol.18, 6, 2017,pp 651-673
2014HDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 DiabetesGebski, Val; Jenkins, Alicia; Keech, Anthony (Tony); O'Connell, Rachel; Waldman, Boris; Davis, Timothy M. E.; Ng, Martin K C; Scott, Russell; Taskinen, M.; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials Centre; School of Public Health: NH&MRC Clinical Trials CentreHDL-C and HDL-C/ApoA-I Predict Long-Term Progression of Glycemia in Established Type 2 Diabetes, Diabetes Care, vol.37, 8, 2014,pp 2351-2358